Binder Information
Binder General Information | Top | |||
---|---|---|---|---|
Binder ID |
BIRP38
|
|||
Binder Name |
Rizatriptan benzoate
|
|||
Synonyms |
Maxalt; Rizatriptan (benzoate); MK 462; MK-462; MK-0462; UNII-WR978S7QHH; WR978S7QHH; N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate; Rizatriptan Benzoate (Maxalt); MK 0462; L 705126; L 705,126; L-705,126; Rizatriptan benzoate [USAN:USP]; rizatrimptan benzoate; rizatriptane benzoate; rizatriptan, benzoate; SCHEMBL41226; MLS001424197; Rizatriptan Benzoate(Maxalt)/; RIZATRIPTAN BENZOATE SALT; CHEMBL1201032; KS-00000XKR; Rizatriptan benzoate (JAN/USP); DTXSID20162937; RHB-103; HMS2051B16; HMS2093K08; HMS2235M18; HMS3369I15; HMS3393B16; HMS3655K09; HMS3715D08; HMS3884K21; Pharmakon1600-01505189; ACT04340; BCP02149; HY-B0206; INT-0008; ABP000203; AC-734; MFCD00866224; NSC758919; AKOS015855933; AB07521; CCG-101039; KS-1189; NC00289; NSC-758919; 3-(2-(Dimethylamino)ethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)indole monobenzoate; AK163196; SMR000525252; AB0011227; DB-015783; Rizatriptan benzoate salt, >=98% (HPLC); FT-0631171; R0107; R0181; S1607; SW197669-2; D00675; X-2040; 202R660; SR-01000763588; J-008071; J-524222; SR-01000763588-3; Q27292788; Rizatriptan benzoate, European Pharmacopoeia (EP) Reference Standard; Rizatriptan benzoate, United States Pharmacopeia (USP) Reference Standard; DIMETHYL-[2-(5-[1,2,4]TRIAZOL-1-YLMETHYL-1H-INDOL-3-YL)-ETHYL]-AMINE BENZOATE; N,N-DIMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1H-INDOLE-3-ETHANAMINE BENZOATE
Click to Show/Hide
|
|||
Binder Type |
Small molecular drug
|
|||
Structure |
Download2D MOL
|
|||
Formula |
C22H25N5O2
|
|||
Canonical SMILES |
CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O
|
|||
InChI |
1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)
|
|||
InChIKey |
JPRXYLQNJJVCMZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:8875
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.